ow dose zoledronate in postmenopausal women with thin bones

Phase 4

Completed

• Conditions: Osteoporosis; Musculoskeletal - Osteoporosis

• Registration Number: ACTRN12607000576426
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-11-09
• Study Completion: 2019-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 180

Inclusion Criteria

Postmenopausal women
Bone density T Score < -1 and > -2.5 at lumbar spine or total hip

Exclusion Criteria

kidney, liver, thyroid or parathyroid dysfunction
current cancer
osteoporosis
vitamin D deficiency
medications known to influence bone metabolism

Study & Design

• Study Type: Interventional
• Study Design: Not specified